Nutritional Ketosis Marfan

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-50
SponsorWashington University School of Medicine

About this trial

In this pilot clinical trial, the investigators will test whether a carefully supervised ketogenic diet can safely help people with Marfan syndrome who already have a chronic or residual aortic dissection. Fifteen participants will work with a study coordinator and dietitian to learn how to follow the diet and will have regular guidance and check-ins. The participants will measure their blood ketone levels at home with a simple finger-stick device and relay their readings to the research team. Every three months, blood samples will also be collected to confirm the body's level of ketosis.

Participants will continue their usual heart and blood-pressure medicines and regular visits with their doctors. Standard of care computed tomography (CT) scans of the aorta will be performed at the start of the study and then again at 6 and 12 months to see if the aorta changes in size.

The main goal is to see how many patients can avoid needing aortic surgery within one year, compared with what is normally expected from past studies. The investigators will also track how well patients follow the diet, how their aorta changes, and whether inflammation in their blood decreases.

Eligibility criteria

Qualifiers

Adults between 18 and 50 years old.

Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document.

Genetically or clinically confirmed Marfan syndrome

Chronic descending thoracic aortic dissection present for at least three months

Disqualifiers

Acute or rapidly enlarging dissection (>0.5 cm increase over the preceding three months)

Prior descending thoracic aortic repair or endograft placement

Advanced renal or hepatic dysfunction

Poorly controlled diabetes requiring insulin

Trial design

Treatments tested in this trial

  • Ketogenic diet

Treatment groups

15 Participants
are divided into 1 treatment group

Locations

This trial has no locations